Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

Bay Area health research roundup: Alzheimer's disease drug result encouraging
August 8, 2012

A common anti-epileptic drug may be able to reverse some of the memory loss and behavioral changes associated with Alzheimer's disease, according to scientists at the Gladstone Institutes.

Un medicamento contra la epilepsia podría devolver la memoria a pacientes con Alzheimer
August 8, 2012

Ahora parece ser que un medicamento ampliamente utilizado para tratar la epilepsia podría tratar también el Alzheimer, devolviendo la memoria a los pacientes que sufran esta enfermedad neurodegenerativa.

La piste prometteuse des traitements antiépileptiques pour lutter contre la maladie d'Alzheimer
August 8, 2012

Un anti-épileptique peut-il restaurer la mémoire? Une équipe franco-américaine a découvert que le lévétiracétam, déjà commercialisé pour traiter certaines épilepsies, améliore les symptômes de souris atteintes d'une maladie d'Alzheimer expérimentale.

Nanofibers May Quicken Healing After Heart Attacks
August 8, 2012

Gladstone's Dr. Benoit Bruneau weighs in on new research showing that nanofibers may help speed healing after heart attacks, preventing heart failure and improving quality of life.

Alzheimer : un nouveau traitement prometteur
August 8, 2012

C'est le cas dans une étude menée depuis trois ans à l'Institut Gladstone: les chercheurs ont découvert qu'un médicament contre l'épilepsie réduit, entre autres, la perte de mémoire, principale conséquence de la maladie d'Alzheimer.

ALZHEIMER: Un antiépileptique rétablit la mémoire chez la souris – Gladstone Institutes – PNAS
August 7, 2012

Un antiépileptique pourrait bien rétablir la mémoire dans la maladie d'Alzheimer, selon cette étude du Gladstone Institutes, soutenue, entre autres institutions par les National Institutes of Health.

Old Drug, New Hope: Anticonvulsant Reverses Alzheimer's-Related Memory Loss
August 7, 2012

In an animal model of the disease, scientists at the University of California, San Francisco-affiliated Gladstone Institutes have discovered that Levetiracetam - an FDA-approved drug commonly prescribed for patients who suffer from epilepsy, reverses memory loss and alleviates other Alzheimer's-related impairments.

Gladstone researchers find epilepsy drug that may work for Alzheimer's patients
August 6, 2012

A drug that already curbs epileptic seizures could be used to reverse memory loss and other brain functions in some Alzheimer's disease patients, researchers at the Gladstone Institutes discovered.

Epilepsy drug reverses memory loss in animal model of Alzheimer's disease
August 6, 2012

Scientists in the laboratory of Lennart Mucke, MD discovered that the FDA-approved anti-epileptic drug levetiracetam restores memory function in mice genetically modified to simulate key aspects of Alzheimer's disease.

Best Places to Work Academia, 2012
August 1, 2012

Topping this year’s survey of academic researchers is the Gladstone Institutes, a San Francisco-based nonprofit biomedical research organization with a focus on cardiovascular disease, virology and immunology, and neurodegenerative disorders that also won the top honors last year.